Scleroderma Newsroom
ISN News Manager: Jo Frowde
Media Stories
Scleroderma Archive
2015: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2016 - 2015 - 2014 - 2013

April 2015 Scleroderma News

Investigational Scleroderma Drug Takes Novel Approach To Treating Inflammation. A new proposed treatment for scleroderma, Resunab, will soon be in Phase 2 clinical trials. Scleroderma News, 03/16/2015. (Also see Scleroderma Clinical Trials: Resunab)

New Study Summarizes Scientific Findings Concerning Scleroderma Renal Crisis (SRC). SRC is still affecting a meaningful population of patients with systemic sclerosis, so a vigilant diagnosis and therapy is needed to prevent adverse outcomes and enhance survival. Seminars in Arthritis and Rheumatism, 02/27/2015. (Also see Scleroderma Renal Crisis)

Researchers Report Audiovestibular Dysfunction in Systemic Sclerosis Patients. There is an association between systemic sclerosis and inner ear function resulting in audiovestibular abnormalities. The Egyptian Rheumatologist, 02/26/2015. (Also see Autoimmune Ear Diseases)

A preliminary study of acoustic radiation force impulse (ARFI) quantification for the assessment of skin in diffuse cutaneous systemic sclerosis (dSSc). ARFI quantification is feasible and reliable for assessing the skin involvement in dcSSc and may be a valuable adjunct to skin evaluation in patients with SSc. PubMed, J Rheumatol, 2015 Mar;42(3):449-55. (Also see Skin Fibrosis)

Decreased numbers of endothelial progenitor cells (EPCs) in patients in the early stages of systemic sclerosis (SSc). Decreased EPCs in SSc patients might be an important therapeutic target for the prevention of vascular complications. PubMed, Microvasc Res, 2015 Jan 13;98C:82-87. (Also see Vascular Involvement in Systemic Scleroderma)

A reactive oxygen species(ROS)-mediated loop maintains the increased expression of NOX2 and NOX4 in skin fibroblasts from patients with systemic sclerosis (SSc). NOX2 and NOX4 generate ROS in SSc fibroblasts and play a critical role in cell activation and DNA damage. PubMed, Arthritis Rheumatol, 02/23/2015. (Also see Causes of Scleroderma: Fibroblasts)

Early systemic sclerosis-opportunities for treatment. The early diagnosis of SSc, before the development of fibrosis in internal organs, will allow the introduction of immunosuppressive medications in these patients in a controlled setting. PubMed, Clin Rheumatol, 02/26/2015. (Also see Common Medical Tests for Scleroderma)

Interstitial Lung Disease in Scleroderma. The diagnosis of interstitial lung disease hinges on careful clinical evaluation and pulmonary function tests and high-resolution computed tomography. Rheumatic Disease Clinics of North America, 03/05/2015. (Also see Pulmonary Fibrosis Diagnosis)

Generalised calcinosis in systemic sclerosis. Calcinosis can be painful, complicated by secondary infections and lesions have been identified in a variety of areas such as hand, wrist, forearm, elbow, shoulder and spinal or gluteal regions. Indian Journal of Rheumatology, 02/26/2015. (Also see Calcinosis)

Go to Scleroderma Medical News: March 2015
Most Recent Donors

Winn Schillberg
Reading Voices of Scleroderma Books: Diana Kramer.
Sharing Scleroderma Awareness Bracelets: Deb Martin, Brenda Miller, Vickie Risner.
Thanks to UNITED WAY donors of Central New Mexico and Snohomish County!

In Loving Memory

Patricia Ann Black: Marilyn Currier, Shelley Ensz, Richard Howitt, Gerald and Pat Ivanejko, Juno Beach Condo Association, Keith and Rosalyn Miller, and Elaine Wible.
Gayle Hedlin: Daniel and Joann Pepper and Nancy Smithberg.
Janet Paulmenn: Anonymous, Mary Jo Austin, Shelley Blaser, Susan Book, Dennis and Pat Clayton, Grace Cunha, Cindy Dorio, Michael and Patricia Donahue, Shelley Ensz, Nancy Falkenhagen, Jo Frowde, Alice Gigl, Margaret Hollywood, Karen Khalaf and Family, Susan Kvarantan, Bradley Lawrence, Jillyan Little, Donna Madge, Michele Maxson, Barry and Judith McCabe, John Moffett, My Tribute Foundation, Joan-Marie Permison, John Roberts, Margaret Roof, Maryellen Ryan, Mayalin and Kiralee Murphy, Nancy Settle-Murphy, and Bruce and Elizabeth Winter.


SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA

Email [email protected] to request our Welcome email, or to report bad links or to update this page content.

TOLL FREE HOTLINE 800-564-7099
Free to U.S. and Canadian Callers. Ask for our Free Info Packet by mail or email!
Scleroderma, Pulmonary Arterial Hypertension, and related illnesses.
Privacy Policy.

The most important thing in the world to know about scleroderma is!
Donate Now
Copyright 1998-2016, International Scleroderma Network. AKA Scleroderma from A to Z and SCLERO.ORG. All Rights Reserved.